Back to Annual Meeting

Back to Annual Meeting

Abstract #162634

• Audio (mp3) recording
• Slides (pdf) or Handout

Paul A. Young, MBA, MPH¹, Amanda Greene, PHD, MPH, FNP, RN¹, and Rosemary Wong, PhD². (1) NOVA Research Company, 4600 East-West Highway, Suite 700, Bethesda, MD 20814-6900, (301) 986-1891, payoung@novaresearch.com, (2) National Cancer Institute, Radiation Research Program, Division of Cancer Treatment and Diagnosis, 6130 Executive Boulevard, Suite 6000, Rockville, MD 20892

This presentation describes steps in evaluating an established, ongoing research program. NCI's CDRP is a 5-year cooperative U 56 grant program that began in 2002. CDRP focuses on building and stabilizing clinical trials research programs in community-based institutions that care for a disproportionate number of medically underserved, low-income, and racial/ethnic minority populations and are not traditionally involved in NCI-sponsored research. CDRP components include: (1) providing radiation oncology clinical trials to target populations experiencing cancer health disparities who otherwise might not have the opportunity to participate; (2) implementing partnerships between community institutions and academic cancer research institutions; (3) establishing a telemedicine system at each CDRP institution to augment patient care and research; (4) supporting patient navigators to facilitate access to oncology services, including clinical trials, by addressing barriers that impact timely cancer care delivery; and (5) conducting community outreach related to health care and cancer research. Using a non traditional funding mechanism, CDRP funds six community-based institutions across the United States. Evaluation planning began 3 years after initiation of CDRP. The first step in evaluating CDRP was clear delineation of goals and objectives and building a Logic Model, which facilitated addressing stakeholder concerns. Because each CDRP project community is unique, the evaluation design must accommodate similarities and differences among these programs. Using a mixed-method evaluation design, individual components, linkages between these, and the overall program at each CDRP site and across all sites are examined. Challenges and successes in evaluating this multi-component program will be discussed.

Learning Objectives:

• Describe steps in evaluating an ongoing program;
• Discuss methods for evaluating individual CDRP components, linkages between Program components, and the overall program;
• Discuss challenges and successes in evaluating an ongoing program.

Keywords: Cancer, Evaluation

Related Web page: www3.cancer.gov/rrp/cdrp/index.html

Presenting author's disclosure statement:

Any relevant financial relationships? Yes

Name of Organization	Clinical/Research Area	Type of relationship
NOVA Research Company	Program Evaluation	Employment (includes retainer) and Stock Ownership

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

• Audio (mp3) recording
• Slides (pdf) or Handout